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The goal of the present study is to examine the agonist action of nornicotine on
insect nicotinic acetylcholine receptors. Using patch-clamp techniques on cockroach
dorsal unpaired median neurons, we demonstrated that nornicotine induced two
distinct ionic currents named types 1 and 2. We found that alpha-bungarotoxin
induced a rapid desensitization of type 1 currents whereas type 2 was completely
blocked. Interestingly, types 1 and 2 currents were not blocked by the muscarinic
antagonist, pirenzepine but by co-application of 1 muM pirenzepine and 0.5 muM
alpha-bungarotoxin, suggesting that muscarinic receptors modulated nornicotine-
induced current amplitudes. In addition, type 1 current amplitudes were strongly
reduced by 20 muM d-tubocurarine and 5 muM mecamylamine which blocked the
previously identified alpha-bungarotoxin-insensitive nAChR1 and nAChR2 receptors.
Co-application of alpha-bungarotoxin with d-tubocurarine or mecamylamine
completely blocked all ionic currents. We propose that types 1 and 2 currents are
associated to several nicotinic receptors subtypes, including nAChR1 and nAChR2
receptors. Finally, we conclude that nornicotine could be used as an agonist to
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